OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2015-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 26269774PMCID PMC4529590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic Resonance Imaging Physical Principles And Sequence Design

  2016cited by this paper
• Imaging the microvessel caliber and density: Principles and applications of microvascular MRI

  2015influential reference
• Imaging angiogenesis, inflammation, and metastasis in the tumor microenvironment with magnetic resonance imaging.

  2014influential reference
• Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.

  2013influential reference
• Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature

  2013cited by this paper
• Reactive Oxygen Species in Vascular Formation and Development

  2013cited by this paper
• Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity.

  2013cited by this paper
• A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes

  2013cited by this paper
• Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

  2013influential reference
• Imaging tumor angiogenesis: the road to clinical utility.

  2013cited by this paper
• Angiogenic Signalling Pathways Altered in Gliomas: Selection Mechanisms for More Aggressive Neoplastic Subpopulations with Invasive Phenotype

  2012cited by this paper
• Antiangiogenic Therapy for Glioma

  2012influential reference
• Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.

  2012cited by this paper
• Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.

  2012cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

  2012cited by this paper
• Conditional probability of long‐term survival in glioblastoma

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species.

  2011cited by this paper
• Anti-cancer activity of nitrones and observations on mechanism of action.

  2011cited by this paper
• Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy.

  2011cited by this paper
• Imaging biomarkers of brain tumour margin and tumour invasion.

  2011cited by this paper
• Multiparametric assessment of the anti‐glioma properties of OKN007 by magnetic resonance imaging

  2010cited by this paper
• MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targeting.

  2010cited by this paper
• Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas

  2010influential reference
• Endogenous avidin biotin activity (EABA) in thyroid pathology: immunohistochemical study

  2009cited by this paper
• Molecular Magnetic Resonance Imaging Approaches Used to Aid in the Understanding of Angiogenesis In Vivo: Implications for Tissue Engineering

  2009cited by this paper
• Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.

  2009cited by this paper
• Multimodality Molecular Imaging of Tumor Angiogenesis

  2008cited by this paper
• Nitrones as therapeutics.

  2008cited by this paper
• Angiogenesis in brain tumours

  2007cited by this paper
• Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression.

  2007cited by this paper
• Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.

  2007cited by this paper
• Investigating the free radical trapping ability of NXY-059, S-PBN and PBN

  2007cited by this paper
• Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.

  2006cited by this paper
• Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures.

  2006cited by this paper
• Masters of angiogenesis

  2005influential reference
• Angiogenic inhibitors: a new therapeutic strategy in oncology

  2005cited by this paper
• Uptake, localization, and noncarboxylase roles of biotin.

  2005cited by this paper
• Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.

  2005cited by this paper
• Angiogenesis in Gliomas: Imaging and Experimental Therapeutics

  2005cited by this paper
• Vascular Endothelial Growth Factor and Angiogenesis

  2004influential reference
• Angiogenesis and invasion in gliomas.

  2004cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper‐permeability and lymphatic uptake, followed by rapid inactivation of the growth factor

  2002cited by this paper
• Reactive oxygen generated by Nox1 triggers the angiogenic switch

  2002cited by this paper
• Longer Life Spans and Delayed Maturation in Wild-Derived Mice

  2002cited by this paper
• Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.

  2002cited by this paper
• Determination of intracranial tumor volumes in a rodent brain using magnetic resonance imaging, Evans Blue, and histology: a comparative study

  2000cited by this paper
• Angiogenesis and tumor metastasis.

  1998cited by this paper
• Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms

  1994cited by this paper
• Spin trap salvage from endotoxemia: the role of cytokine down-regulation.

  1992cited by this paper
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

  1992cited by this paper
• Electron microscopic visualization of sites of nascent DNA synthesis by streptavidin-gold binding to biotinylated nucleotides incorporated in vivo

  1988cited by this paper

• Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.

  2023cites this paper
• OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera

  2022cites this paper
• Pre-Clinical Models and Potential Novel Therapies for Glioblastomas

  2021cites this paper
• A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007

  2021cites this paper
• In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis

  2020cites this paper
• Assessing bladder hyper-permeability biomarkers in vivo using molecularly-targeted MRI.

  2020cites this paper
• OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma

  2020cites this paper
• Synthesis and evaluation of 13C‐labeled 5‐5‐dimethyl‐1‐pyrroline‐N‐oxide aimed at in vivo detection of reactive oxygen species using hyperpolarized 13C‐MRI

  2019cites this paper
• Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis

  2018cites this paper
• OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth

  2018cites this paper
• OKN-007 Increases temozolomide ( TMZ ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma ( GBM ) Tumor Growth 1

  2018cites this paper
• Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.

  2017cites this paper
• Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.

  2017cites this paper
• Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme (Review).

  2016cites this paper